Samjin Pharmaceuticals Co., Ltd. (KRX:005500)
19,490
-110 (-0.56%)
At close: Nov 4, 2025
Samjin Pharmaceuticals Market Cap
Samjin Pharmaceuticals has a market cap or net worth of 238.9 billion as of November 5, 2025. Its market cap has increased by 1.47% in one year.
Market Cap
238.90B
Enterprise Value
n/a
Revenue
274.03B
Ranking
n/a
PE Ratio
11.28
Stock Price
19,490.00
Market Cap Chart
Since August 30, 1995, Samjin Pharmaceuticals's market cap has increased from 29.12B to 238.90B, an increase of 720.42%. That is a compound annual growth rate of 7.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 4, 2025 | 238.90B | 7.80% |
| Dec 30, 2024 | 221.61B | -19.69% |
| Dec 28, 2023 | 275.94B | -19.80% |
| Dec 29, 2022 | 344.07B | 5.06% |
| Dec 30, 2021 | 327.51B | -3.49% |
| Dec 30, 2020 | 339.34B | 9.22% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 86.90T |
| Celltrion | 38.84T |
| ALTEOGEN | 29.36T |
| SK Biopharmaceuticals | 9.42T |
| Yuhan | 9.01T |
| HLB Co., Ltd. | 7.03T |
| Peptron | 6.33T |
| ABL Bio | 6.13T |